Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Psychopharmacology|April 15, 2019
A potential role for the gut microbiome in substance use disordersKatherine R Meckel, Drew D Kiraly
Neuropharmacology|May 9, 2021
Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disordersKelsey E Lucerne, Aya Osman, Katherine R Meckel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 15, 2021
Alterations in microbiome composition and metabolic byproducts drive behavioral and transcriptional responses to morphineRebecca S Hofford, Nicholas L Mervosh, Tanner J Euston, et al.
Eneuro|January 2, 2024
Microbiome Depletion Increases Fentanyl Self-Administration and Alters the Striatal Proteome Through Short-Chain Fatty AcidsRebecca S Hofford, Katherine R Meckel, Elizabeth J Wiser, et al.
International Journal of Adolescent Medicine and Health|November 21, 2014
Suicidal behavior in a medical professional with comorbid depression and substance use disorder: an educational case reportDrew D Kiraly, Leo Sher
International Journal of Adolescent Medicine and Health|December 22, 2014
Low testosterone in a young combat veteran with dual diagnosis and suicidal behavior: a case studyDrew D Kiraly, Leo Sher
Annals of the New York Academy of Sciences|August 14, 2025
Microbiome-derived metabolites in substance use disorders: Mechanisms and implicationsMarta Koperska, Drew D Kiraly
International Review of Neurobiology|March 2, 2021
The role of gut-immune-brain signaling in substance use disordersKelsey E Lucerne, Drew D Kiraly
Biological Psychiatry|August 12, 2023
Clinical and Preclinical Evidence for Gut Microbiome Mechanisms in Substance Use DisordersRebecca S Hofford, Drew D Kiraly
Pageof 6